TMEM161B-AS1: a pivotal long non-coding RNA in the pathogenesis of glioblastoma revealed by Mendelian randomization analysis
International Journal of Clinical and Experimental Pathology · 2026
DOI: 10.62347/atch1081 ↗At a glance
Journal article in International Journal of Clinical and Experimental Pathology, 2026. Written by Ya-Li Yan and 5 co-authors. Institution: Ministry of Scientific Research, The First Hospital of Hohhot Hohhot 010018, Inner Mongolia, China. 37 references. The full text is freely available in PubMed Central.
Abstract (original language)
OBJECTIVES: The significance of long non-coding RNAs (lncRNAs) in glioblastoma multiforme (GBM) has been acknowledged, but their specific role in the pathogenesis of GBM has not been thoroughly investigatedr. This study aimed to investigate the involvement of lncRNAs in the pathogenesis of GBM. METHODS: We collected GBM tissues from four patients and corresponding para-carcinoma controls samples, and used HiSeq sequencing to generate lncRNA expression profiles in GBM. To identify lncRNAs associated with GBM, we employed Mendelian randomization (MR), leveraging the comprehensive extensive expression data obtained from HiSeq sequencing to infer causal relationships. Expression quantitative trait loci (eQTLs) for brain tissues were accessed from the Genotype-Tissue Expression (GTEx) Portal. Subsequently, we conducted an integrative analysis combining brain cancer genome-wide association study (GWAS) summary data (finn-b-C3_GBM) with eQTL data using MR. Differentially expressed lncRNAs were intersected with MR results to identify lncRNA candidates. Subsequently, the ENCORI database was used to identify genes regulated by the candidate lncRNAs, and Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analyses were performed. RESULT: A protein-protein interaction (PPI) network was constructed to identify hub genes associated with GBM, and these findings were validated using the Gene Expression Profiling Interactive Analysis 2 (GEPIA2) tool. A total of 106 lncRNAs exhibited significant alterations in expression levels (|log2(fold change)| > 1 and P < 0.05) in GBM tissues. Through Mendelian randomization (MR) analysis, TMEM161B-AS1 emerged as a promising candidate lncRNA. Genes regulated by TMEM161B-AS1 were significantly enriched in biological processes such as DNA replication and repair, cellular response to DNA damage stimuli, and pathways including the peroxisome proliferator-activated receptor signaling pathway, nucleotide excision repair, and the Fanconi anemia pathway. The differential expression of hub genes CUL4A, RPA1, and BRIP1 was validated using the GEPIA2 database. CONCLUSIONS: These findings suggest pathways for the development of more precise and sensitive biomarkers for the diagnosis and management of GBM, which may ultimately enhance patient outcomes.
Subjects
Author keywords
Authors and institutions
- Ministry of Scientific Research, The First Hospital of Hohhot Hohhot 010018, Inner Mongolia, China.
- The Clinical Genetic Laboratory, The First Hospital of Hohhot Hohhot 010018, Inner Mongolia, China.
- Department of Neurology, The People's Hospital of Inner Mongolia Hohhot 010018, Inner Mongolia, China.
Cite
APA
Yan, Y. L., Zhang, J. W., Liu, B., Bai, P., Zhen, J., & Wang, S. C. (2026). TMEM161B-AS1: a pivotal long non-coding RNA in the pathogenesis of glioblastoma revealed by Mendelian randomization analysis. International Journal of Clinical and Experimental Pathology. https://doi.org/10.62347/atch1081
Vancouver
Yan YL, Zhang JW, Liu B, Bai P, Zhen J, Wang SC. TMEM161B-AS1: a pivotal long non-coding RNA in the pathogenesis of glioblastoma revealed by Mendelian randomization analysis. International Journal of Clinical and Experimental Pathology. 2026. doi:10.62347/atch1081
BibTeX
@article{Yan2026,
author = {Yan, Ya-Li and Zhang, Jia-Wei and Liu, Bin and Bai, Peng and Zhen, Jin and Wang, Shi-Chao},
title = {TMEM161B-AS1: a pivotal long non-coding RNA in the pathogenesis of glioblastoma revealed by Mendelian randomization analysis},
journal = {International Journal of Clinical and Experimental Pathology},
year = {2026},
doi = {10.62347/atch1081}
}
EUVIMED